jueves, 25 de enero de 2018

Big Pharma. Ganan...los accionistas (shareholders)


That's nice for shareholders of these companies, but not great news for investors hoping for a sudden surge in mergers and acquisitions.

J&J was one of the few companies that went beyond vague comments about flexibility and investment. It said U.S. companies that generate a lot of cash overseas have tended to leave it there to avoid tax consequences, while raising a bunch of debt in the U.S. to fund spending here. Now, J&J -- and perhaps others with large overseas cash holdings -- will likely pay down a chunk of that debt.(Más)

No hay comentarios: